India
The fund will buy equity stakes in companies that plan to list within 18 months.
1
PE-led consortium to buy Novartis India unit in $159m deal
2
IFC weighs up to $8.5m investment in Quadric to expand India R&D
3
Schroders Capital taps Oaktree MD to bolster Asia fundraise
4
Beyond the Buyout: Is SE Asia’s secondaries market near a turning point?
5
Private equity interest in SE Asia’s education market holds firm
More Stories
Vietnam data centres draw private capital, but structural bottlenecks remain
Sea Ltd inks deal with Google to deploy agentic AI across its ecosystem
Qverse launches private credit strategy, eyes Singapore expansion
From food to energy: January’s PE deal scorecard in India signals a shift
The transaction follows the company’s $109m syndicated loan facility last year.
The funding also saw participation from Z47, RTP Global, and Fundamentum Partnership.
Rest of Asia
The fund aims to raise over $130m in next 18 months.
Singapore
The partnership will expedite V-Key’s product innovation and expand its regional presence.
With Fund II, W Health plans to build and scale 8-10 new companies over the next four years.
The category II alternative investment fund is targeting a total corpus of Rs 5,000 crore.
The results mark Softbank’s fourth consecutive quarter in the black.
Philippines
It has completed cross-border loan facilities to Billease, Country Funders & First Circle.
Malaysia
Seedflex last raised $3.2m in a seed extension in May 2025 co-led by ZVC and Iterative.
